https://healthtree.org/aml/community/podcasts/healthtree-for-aml-radio--gabriel-mannis-md-stanford-cancer-institute
https://healthtree.org/aml/community/podcasts/harnessing-the-immune-system-in-relapsed-aml--dr-john-reagan-rhode-island-hospital
https://healthtree.org/aml/community/podcasts/the-latest-in-aml-treatment-advances--where-we-are-and-where-were-going-with-james-blachly-md-ohio-state-university-2
https://healthtree.org/aml/community/podcasts/healthtree-radio-for-aml--aml-progress-in-2021-and-a-look-to-the-future-with-dr-eytan-stein-
https://healthtree.org/aml/community/podcasts/targeting-flt3-positive-aml-with-new---improved-therapies-2
https://healthtree.org/aml/community/podcasts/healthtree-for-aml-radio--clinical-trials-using-magrolimab-a-monoclonal-antibody-and-immune-checkpoint-inhibitor-in-combination-therapies-to-improve-outcomes-in-aml-with-dr-joseph-jurcic-columbia-university-
https://healthtree.org/aml/community/podcasts/attacking-aml-cells-with-new-immunotherapy-infusion
https://healthtree.org/aml/community/podcasts/weighing-FLT3-inhibitor-options-with-dr-jane-liesveld
https://healthtree.org/aml/community/podcasts/digging-deeper-into-the-tp53-mutation-in-aml-with-rory-shallis-md-yale-new-haven-hospital
https://healthtree.org/aml/community/podcasts/expanding-the-use-of-tibsovo-ivosidenib-to-newly-diagnosed-idh1-mutated-aml-with-eytan-stein-md-memorial-sloan-kettering
https://healthtree.org/aml/community/podcasts/reducing-relapse-risk-after-transplant
https://healthtree.org/aml/community/podcasts/menin-inhibitors-101-aml